Skip Navigation

Bluesight for Controlled Substances Releases New Form Factor to Track Suppositories.

Blog

Bluesight for Controlled Substances Releases New Form Factor to Track Suppositories.

By Hannah Kanfer   Kit Check’s Bluesight for Controlled Substances’ new release includes suppositories as…

Blog

Diversion Quarterly — Q2 2020

Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly…

Blog

A Pharmacist's Perspective: Automating Critical Tasks with David Vu

Dr. David Vu, PharmD, CPHIMS, PMP is a quality assurance engineer at Kit Check. He …

Blog

Using AI to Prevent Diversion, Improve Efficiency, and Ensure Safety

A recent Pharmacy Technology Report article highlighted how Kit Check partner Children’s Hospital of the …

Blog

Kit Check Hospital Pharmacy Operations Report Reveals Over a Third of Hospital Pharmacy Professionals Are Aware of at Least One Colleague Who Has Stolen Controlled Substances

 Report shows diversion, shortages, and patient safety among top priorities for pharmacy personnel WASHINGTON (APRIL …

Blog

Diversion Quarterly — Q1 2020

Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly …

Blog

Premier Inc. Designates Kit Check as "Essential Business"

In this unprecedented time in America, especially in healthcare, we at Kit Check are honored …

Blog

Bluesight Med Tracking in the Fight Against COVID-19

Every day brings new information about the fight against the COVID-19 virus. Last week it …

Blog

Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report

KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering …

Blog

Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders

Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical …

1 of 3